A comprehensive view of Generics / Biosimilars. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

LA SB444: Pharmaceutical Reimbursement Regulation
Published: May 14, 2024 by Louisiana 2024 Regular Session
IL SB2672: Pharmaceutical companies must report generic drug shortages to the Illinois Department of Insurance.
Published: May 14, 2024 by Illinois 103rd General Assembly
Boehringer Ingelheim to manufacture citrate-free adalimumab-adbm for Quallent Pharmaceuticals; Boehringer will continue to commercialize Boehringer Ingelheim-labeled Cyltezo adalimumab-adbm injection and Adalimumab-adbm
Published: May 13, 2024 by PR Newswire
NY A10185: Insurers must cover brand-name drugs when generics are in short supply.
Published: May 10, 2024 by New York 2023-2024 General Assembly
Bristol Myers, Merck, and AbbVie prepare for key patent expirations this decade by focusing on patent extension strategies, developing new drugs, and acquiring smaller biotech startups; tactics are aimed at preventing profit loss from generic competition
Published: May 08, 2024 by Quartz

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count